Works matching IS 0167594X AND DT 2017 AND VI 133 AND IP 3
Results: 25
Radiotherapy for cranial and brain metastases from prostate cancer: a systematic review.
- Published in:
- Journal of Neuro-Oncology, 2017, v. 133, n. 3, p. 531, doi. 10.1007/s11060-017-2460-6
- By:
- Publication type:
- Article
Analysis of surgical and MRI factors associated with cerebellar mutism.
- Published in:
- Journal of Neuro-Oncology, 2017, v. 133, n. 3, p. 539, doi. 10.1007/s11060-017-2462-4
- By:
- Publication type:
- Article
MiR-181b modulates chemosensitivity of glioblastoma multiforme cells to temozolomide by targeting the epidermal growth factor receptor.
- Published in:
- Journal of Neuro-Oncology, 2017, v. 133, n. 3, p. 477, doi. 10.1007/s11060-017-2463-3
- By:
- Publication type:
- Article
MicroRNA-211 expression is down-regulated and associated with poor prognosis in human glioma.
- Published in:
- Journal of Neuro-Oncology, 2017, v. 133, n. 3, p. 553, doi. 10.1007/s11060-017-2464-2
- By:
- Publication type:
- Article
Study of β-catenin and BRAF alterations in adamantinomatous and papillary craniopharyngiomas: mutation analysis with immunohistochemical correlation in 54 cases.
- Published in:
- Journal of Neuro-Oncology, 2017, v. 133, n. 3, p. 487, doi. 10.1007/s11060-017-2465-1
- By:
- Publication type:
- Article
Nivolumab for patients with recurrent glioblastoma progressing on bevacizumab: a retrospective case series.
- Published in:
- Journal of Neuro-Oncology, 2017, v. 133, n. 3, p. 561, doi. 10.1007/s11060-017-2466-0
- By:
- Publication type:
- Article
Ischemic stroke and intracranial hemorrhage in patients with recurrent glioblastoma multiforme, treated with bevacizumab.
- Published in:
- Journal of Neuro-Oncology, 2017, v. 133, n. 3, p. 571, doi. 10.1007/s11060-017-2467-z
- By:
- Publication type:
- Article
Embryonal tumors in Canadian children less than 36 months of age: results from the Canadian Pediatric Brain Tumor Consortium (CPBTC).
- Published in:
- Journal of Neuro-Oncology, 2017, v. 133, n. 3, p. 581, doi. 10.1007/s11060-017-2468-y
- By:
- Publication type:
- Article
A phase II trial of arsenic trioxide and temozolomide in combination with radiation therapy for patients with malignant gliomas.
- Published in:
- Journal of Neuro-Oncology, 2017, v. 133, n. 3, p. 589, doi. 10.1007/s11060-017-2469-x
- By:
- Publication type:
- Article
Radiation necrosis with stereotactic radiosurgery combined with CTLA-4 blockade and PD-1 inhibition for treatment of intracranial disease in metastatic melanoma.
- Published in:
- Journal of Neuro-Oncology, 2017, v. 133, n. 3, p. 595, doi. 10.1007/s11060-017-2470-4
- By:
- Publication type:
- Article
Therapeutic dormancy to delay postsurgical glioma recurrence: the past, present and promise of focal hypothermia.
- Published in:
- Journal of Neuro-Oncology, 2017, v. 133, n. 3, p. 447, doi. 10.1007/s11060-017-2471-3
- By:
- Publication type:
- Article
Rapid resolution of leptomeningeal disease with targeted therapy in a metastatic melanoma patient.
- Published in:
- 2017
- By:
- Publication type:
- Letter
Seizure response to perampanel in drug-resistant epilepsy with gliomas: early observations.
- Published in:
- Journal of Neuro-Oncology, 2017, v. 133, n. 3, p. 603, doi. 10.1007/s11060-017-2473-1
- By:
- Publication type:
- Article
Epithelial growth factor receptor expression influences 5-ALA induced glioblastoma fluorescence.
- Published in:
- Journal of Neuro-Oncology, 2017, v. 133, n. 3, p. 497, doi. 10.1007/s11060-017-2474-0
- By:
- Publication type:
- Article
Clinical presentation and prognostic indicators in 100 adults and children with neurofibromatosis 1 associated non-optic pathway brain gliomas.
- Published in:
- Journal of Neuro-Oncology, 2017, v. 133, n. 3, p. 609, doi. 10.1007/s11060-017-2475-z
- By:
- Publication type:
- Article
Epigenetically controlled Six3 expression regulates glioblastoma cell proliferation and invasion alongside modulating the activation levels of WNT pathway members.
- Published in:
- Journal of Neuro-Oncology, 2017, v. 133, n. 3, p. 509, doi. 10.1007/s11060-017-2476-y
- By:
- Publication type:
- Article
The role of bevacizumab in the treatment of glioblastoma.
- Published in:
- Journal of Neuro-Oncology, 2017, v. 133, n. 3, p. 455, doi. 10.1007/s11060-017-2477-x
- By:
- Publication type:
- Article
MGMT promoter methylation status as a prognostic factor for the outcome of gamma knife radiosurgery for recurrent glioblastoma.
- Published in:
- Journal of Neuro-Oncology, 2017, v. 133, n. 3, p. 615, doi. 10.1007/s11060-017-2478-9
- By:
- Publication type:
- Article
Health-related quality of life outcomes from CABARET: a randomized phase 2 trial of carboplatin and bevacizumab in recurrent glioblastoma.
- Published in:
- Journal of Neuro-Oncology, 2017, v. 133, n. 3, p. 623, doi. 10.1007/s11060-017-2479-8
- By:
- Publication type:
- Article
Diffuse midline skull base meningiomas: identification of a rare and aggressive subgroup of meningiomas.
- Published in:
- Journal of Neuro-Oncology, 2017, v. 133, n. 3, p. 633, doi. 10.1007/s11060-017-2480-2
- By:
- Publication type:
- Article
The Simpson grading in meningioma surgery: does the tumor location influence the prognostic value?
- Published in:
- Journal of Neuro-Oncology, 2017, v. 133, n. 3, p. 641, doi. 10.1007/s11060-017-2481-1
- By:
- Publication type:
- Article
Evaluation of mitochondrial respiratory function in highly glycolytic glioma cells reveals low ADP phosphorylation in relation to oxidative capacity.
- Published in:
- Journal of Neuro-Oncology, 2017, v. 133, n. 3, p. 519, doi. 10.1007/s11060-017-2482-0
- By:
- Publication type:
- Article
MGMT promoter methylation status: time for a frank discussion.
- Published in:
- 2017
- By:
- Publication type:
- Letter
Factors associated with supportive care needs in glioma patients in the neuro-oncological outpatient setting.
- Published in:
- Journal of Neuro-Oncology, 2017, v. 133, n. 3, p. 653, doi. 10.1007/s11060-017-2484-y
- By:
- Publication type:
- Article
Next-Generation Sequencing-based genomic profiling of brain metastases of primary ovarian cancer identifies high number of BRCA-mutations.
- Published in:
- Journal of Neuro-Oncology, 2017, v. 133, n. 3, p. 469, doi. 10.1007/s11060-017-2459-z
- By:
- Publication type:
- Article